user-avatar
Arnne Carragie

Why Is Moderna (MRNA) Stock Up 14.21% Today, Oct 9? NIH Cancer-Vaccine Plans and Nasdaq-100 Return Fuel Rally

Moderna (MRNA) rose 14.21% to $225.00 on October 9, 2026, as its Nasdaq-100 entry took effect and reports revived interest in cancer-treatment research. This draft examines the move, the limits on its interpretation, and the technical levels that could shape the next trading decisions.